|
2025
|
G/S
|
Printed pharmaceutical information leaflets; Printed pamphlets in the field of healthcare, medica... |
|
|
Invention
|
7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e] pyrimidin-5 (1 h)-one,... |
|
2024
|
Invention
|
7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[l,2-a]pyrido[3,4-e] pyrimidin-5 (1 h)-on... |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
Invention
|
Pyrrolopyrimidine nucleosides and analogs thereof.
The present disclosure provides pyrrolopyrimi... |
|
|
Invention
|
7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidaz0[1,2-a]pyrid0[3,4-e] pyrimidin-5 (1 h)-on... |
|
|
Invention
|
7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidaz0[1,2-a]pyrid0[3,4-e] pyrimidin-5 (1 h)-one,... |
|
2023
|
G/S
|
Pharmaceuticals; pharmaceutical preparations. |
|
|
G/S
|
Pharmaceuticals; pharmaceutical preparations |
|
|
G/S
|
Pharmaceuticals; Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceuticals and pharmaceutical preparations for use in the treatment of oncological and neuro... |
|
|
Invention
|
Pharmaceutical compositions and uses thereof for the treatment of glioma. Imipridones selectively... |
|
|
Invention
|
Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7h-pyrr... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of oncological diseases and disorders; pharm... |
|
|
G/S
|
Pharmaceuticals; pharmaceutical preparations for use in the
treatment of oncological and neurolo... |
|
2022
|
G/S
|
Pharmaceuticals; pharmaceutical preparations for use in the treatment of oncological and neurolog... |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
Invention
|
Uses and methods for recurrent primary cns neoplasms.
This disclosure relates, at least in part,... |
|
|
Invention
|
Uses and methods for recurrent primary cns neoplasms. This disclosure relates, at least in part, ... |
|
|
Invention
|
Pyrrolopyrimidine nucleosides for treating or preventing a sars-cov-2 infection.
The present dis... |
|
|
Invention
|
Pyrrolopyrimidine nucleosides for treating or preventing a sars-cov-2 infection. ccand A are defi... |
|
2021
|
G/S
|
pharmaceutical products for the treatment of cancer |
|
|
Invention
|
G protein-coupled receptor (gpcr) modulation by imipridones.
Imipridones has been found to selec... |
|
|
Invention
|
Treatment of acute lung injury. Provided herein are methods and compositions related to using 2-O... |
|
|
Invention
|
Pyrrolopyrimidine nucleosides and analogs thereof. c and A are defined herein. Also presented are... |
|
2020
|
G/S
|
Pharmaceutical preparations for treating viral infections and diseases, namely, cancer, gliomas, ... |
|
|
G/S
|
Pharmaceutical preparations for treating viral infections
and diseases; Pharmaceutical preparati... |
|
|
G/S
|
Pharmaceutical preparations for treating viral infections and diseases; Pharmaceutical preparatio... |
|
2018
|
G/S
|
Pharmaceutical preparations for treating viral infections and diseases; antiviral drugs for medic... |
|
|
Invention
|
Methods of treating retroviral infections and related dosage regimes.
The present invention rela... |
|
|
Invention
|
Treatment of adenovirus with brincidofovir. A conjugate compound comprising an acyclic nucleoside... |
|
2017
|
Invention
|
Methods of treating orthopox virus infections and associated diseases.
The present invention pro... |
|
|
Invention
|
Formulations of brincidofovir. Disclosed are formulations comprising brincidofovir. The formulati... |
|
|
Invention
|
Formulations of brincidofovir.
Disclosed are formulations comprising brincidofovir. The formulat... |
|
|
Invention
|
Methods of treating retroviral infections and related dosage regimes. The present invention relat... |
|
2016
|
Invention
|
Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents. The present disclos... |
|
|
Invention
|
Methods of reducing nephrotoxicity in subjects administered with nucleoside phosphonates.
A conj... |
|
2015
|
G/S
|
Pharmaceutical preparations; drugs for medical purposes; therapeutic drugs and agents; therapeuti... |
|
|
Invention
|
Nucleoside phosphonate salts. The present invention relates to compounds and methods for treating... |
|
2014
|
Invention
|
Branched chain acyclic nucleoside phosphonate esters and methods of synthesis and uses thereof.
... |
|
|
Invention
|
Branched chain acyclic nucleoside phosphonate esters and methods of synthesis and uses thereof. T... |
|
|
Invention
|
Methods of treating viral associated diseases.
The present invention provides methods of treatin... |
|
|
Invention
|
Morphic forms of hexadecyloxypropyl-phosphonate esters. The disclosure describes methods of synth... |
|
2013
|
Invention
|
Compounds, compositions and methods for treating ocular conditions.
The present invention provid... |
|
|
Invention
|
Phosphonate ester derivatives and methods of synthesis thereof.
The disclosure describes methods... |
|
|
Invention
|
Method of treating retroviral infections and related dosage regimes. The present invention relate... |
|
|
Invention
|
A method of mitigating virus associated end-organ damage. The present application provides method... |
|
2012
|
Invention
|
Hexadecyloxypropyl cidofovir for the treatment of double-stranded dna virus infection. The presen... |
|
2011
|
Invention
|
Phosphonate ester derivatives and methods of synthesis thereof. The disclosure describes methods ... |
|
|
Invention
|
Nucleoside phosphonate salts. 1-5 alkyl, or a stereoisomer, a diastereomer, an enantiomer or race... |
|
|
Invention
|
Methods of treating viral infection. The present invention relates to compounds and methods for t... |
|
2010
|
Invention
|
Methods of treating viral associated diseases. The present invention provides methods of treating... |
|
|
Invention
|
Composition and methods of treating viral infections and viral induced tumors. The present invent... |
|
2009
|
Invention
|
Methods of treating viral infections. The present invention provides methods of treating human im... |
|
2007
|
G/S
|
Pharmaceutical drug development services |
